Mitochondrial encephalomyopathies: What next?

Journal of Inherited Metabolic Disease

Volumn 19, Issue 4, 1996, Pages 489-503

  DiMauro, S ^a,b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b 4 420 College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA;

AGING; CONFERENCE PAPER; DEGENERATIVE DISEASE; ENCEPHALOMYOPATHY; GENE MUTATION; GENETIC COUNSELING; HUMAN; PATHOPHYSIOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 0029743399     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01799110     Document Type: Conference Paper

References (13)

1. Agsteribbe E, Huckriede A, Veenhuis M, et al (1993) A fatal, systemic mitochondrial disease with decreased mitochondrial enzyme activities, abnormal ultrastructure of the mitochondria and deficiency of heat shock protein 60. Biochem Biophys Res Commun 193: 146-154.
2. Argov Z, Bank WJ, Maris J, et al (1986) Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study. Ann Neurol 19: 598-602.
3. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337: 508-510.
4. Beal F (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38: 357-366.
5. Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB (1994) Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 36: 882-888.
6. Bendahan D, Desnuelle C, Vanuxem D, et al (1992) 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42: 1203-1208.
7. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S (1996) Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopamy. Neurology, in press.
8. Bourgeron T, Rustin P, Chretien D, et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet 11: 144-149.
9. Bourgeois M, Goutieres F, Chretien D, Rustin P, Munnich A, Aicardi J (1992) Deficiency in complex II of the respiratory chain presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev 14: 404-408.
10. Boustany RN, Aprille JR, Halperin J, Levy H, DeLong GR (1983) Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophthalmoplegia. and lactic acidosis in an infant and as fatal hepatopathy in a second cousin. Ann Neurol 14: 462-470.
11. Bresolin N, Bet L, Binda A, et al (1988) Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10, Neurology 38: 892-899.
12. Calvani M, Koverech A, Caruso G (1993) Treatment of mitochondrial diseases. In: DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York: Raven Press, 173-198.
13. Chen X, Bonilla E, Sciacco M, Schon EA (1995) Paucity of deleted mitochondrial DNAs in brain regions of Huntington's disease patients. Biochim Biophys Acta 1271: 229-233.